台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    102.5
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-鑫永和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-鑫永和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/211102.5000.00102.0011550.64%
2024/05/1700.002105.25105.50-2152-1.31%
2024/05/163106.1700.00107.0031502.00%
2024/05/151103.0000.00104.0011480.67%
2024/05/141101.5000.00102.0011440.69%
2024/04/100125.0000.00127.000950.00%
2024/04/082123.5000.00123.502732.72%
2024/03/1400.000.1119.50119.00-0.143-0.12%
2024/02/010.1112.0000.00112.000.1310.31%
2023/11/131112.5000.00112.501214.74%
2023/11/021114.5000.00115.001204.99%
2023/10/241117.0000.00116.001224.49%
2023/04/122120.0000.00119.002424.70%
2023/04/0600.000.3119.00120.00-0.337-0.79%
2023/03/081116.001114.00116.000340.00%
2022/11/04099.6000.0099.200190.13%
2022/09/2100.001106.00107.00-116-6.04%
2022/09/201107.0000.00107.501166.07%
2022/07/010.197.9000.0096.500.1440.11%
2022/05/160100.0000.0098.700410.10%
2022/04/180125.5000.00125.000250.09%
2022/03/150125.0000.00125.000210.11%
2022/03/020125.0000.00126.000220.13%
2022/02/2400.000.1125.50124.50-0.121-0.46%
2021/12/160.1124.0000.00123.000.1320.31%
2021/12/090124.0000.00122.000320.09%
2021/11/110124.0000.00124.000290.03%
2021/11/100124.0000.00124.000300.08%
2021/11/090126.0000.00124.500290.08%
2021/11/020127.0000.00126.000320.09%
2021/10/180128.5000.00129.000400.09%
2021/10/140.1128.0000.00127.000.1400.19%
2021/09/080.1142.500.2143.50141.00-0.134-0.23%
2021/08/110152.5000.00149.500350.09%
2021/08/0400.003138.50144.00-336-8.16%
2021/08/022155.5000.00155.002345.80%
2021/07/301155.0000.00155.001332.99%
2021/05/120143.0000.00142.000440.04%
2021/05/051144.0000.00144.001392.52%
2021/05/0300.005146.50146.00-538-13.11%
2021/04/271146.5000.00146.001372.63%
2021/04/2300.000.2145.50146.00-0.238-0.53%
2021/04/194147.5000.00147.5043810.52%
2021/03/300.1144.0000.00144.000.1290.17%
2021/02/240.2127.0000.00126.000.2260.76%
2021/01/1100.000.1123.50124.00-0.134-0.16%
2021/01/0800.000.1123.00123.00-0.134-0.38%
2020/11/1800.000.1120.00120.50-0.134-0.38%
2020/11/1600.003117.50119.00-333-8.87%
2020/11/113117.8300.00118.003338.91%
2020/11/100.1115.0000.00116.000.1310.41%
2020/07/0300.001107.50107.50-162-1.60%
2020/06/291107.0000.00107.501621.61%
2020/05/1300.001108.00108.50-148-2.08%
2019/08/271103.0000.00102.001422.38%
2019/01/1700.000.3105.00106.00-0.324-1.11%
2018/11/3000.001105.50105.00-127-3.58%
2018/11/161103.5000.00103.501293.43%
2018/11/121103.001104.00104.000290.00%
2018/11/051106.001106.00106.000300.00%
2018/08/241110.5000.00110.001571.75%
2018/08/2100.001110.00111.00-158-1.70%
2018/06/0500.001126.50126.00-1121-0.82%
2018/06/0400.001125.50125.00-1121-0.82%
2018/05/161125.0000.00125.0011280.78%
2018/05/031128.001129.50129.0001160.00%
2018/04/241122.5000.00122.0011390.72%
2018/04/1700.001122.00122.00-1163-0.61%
2018/03/211128.5000.00128.5011830.54%
2018/01/1700.001122.50121.50-1129-0.77%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音